Oral Acetyl-L-carnitine Therapy Reduces Fatigue In Overt Hepatic Encephalopathy: A Randomized, Double-blind, Placebo-controlled Study

Effect Decrease
Trial Design Double blind
Trial Length n/a
Number of Subjects 121
Sex n/a
Notes for this study:
2g of oral Acetyl-L-Carnitine was able to increase physical activity amounts and reduce fatigue in a sample of persons with hepatic encepalopathy, and decreased ammonia levels in serum over the course of 90 days.

Full details on all 7 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.